Evaluation of quality of life of patients after surgical treatment of kidney cancer

Background. Restoring the quality of life of patients to a level comparable to that of practically healthy people is the most important task of medicine in general. At this stage of development of science, the main goal in the treatment of malignant diseases remains the preservation of life. However, now in oncological practice, methods whose potential allows not only to preserve life as such, but also to ensure the high quality of this life in all its manifestations, are acquiring greater and greater significance.

The objective of the study is to compare the quality of life of persons with localized kidney cancer in the early and late periods after surgical treatment by radical nephroectomy and laparoscopic resection of renal tissue.

Materials and methods. A questionnaire survey using SF-36 (Short Form-36), designed for a comprehensive assessment of the quality of life associated with health.

Results. The quality of life of patients with localized kidney cancer before treatment is reduced due to a number of physical and mental nature, limiting labor, domestic and social activity and causing a feeling of dissatisfaction with their lives in general. These problems are disorders of physical, social and emotional functioning, physical pain, deterioration of general and mental health, limitations of role functioning due to physical and emotional state. After surgical treatment with laparoscopic resection, complete satisfaction of patients with the quality of their life was achieved during the first 1–3 postoperative months; after radical nephroectomy – not earlier than 1–3 years.

Conclusion. One of the advantages of laparoscopic resection over radical nephroectomy is a higher quality of life of patients in the early and late periods after the intervention.

1. Rubanova E.Yu. Theoretical aspects of quality of life in the context of health psychology. Uchenye zametki TOGU = Scientists Notes PNU 2014;5(3):108–15. (In Russ.).

2. Novik A.A., Ionova T.I. Guidelines on quality of life studies in medicine. Moscow: OLMA-PRESS, 2002. 314 p. (In Russ.).

3. Poyda A.I., Melnik V.M., Zaverniy L.G., Abu Shamsiya R.N. Patients quality of life after colorectal cancer surgery. Klinicheskaya onkologiya = Clinical Oncology 2011;special issue I:47–52. (In Russ.).

4. Bratslavsky G., Boris R. Emerging strategies of nephron sparing surgery in patients with localized and recurrent renal cell carcinoma. Zlokachestvennie opukholi = Malignant Tumors 2011;1:11–20. (In Russ.).

5. Komyagina Yu.M. Partial nephrectomy in renal caner. Bulleten meditsinskikh internet-conferentsiy = Bulletin of Medical Internet Conferences 2013;2:365. (In Russ.).

6. Ivanov P.M. Surgical treatment of kidney cancer. Mezhdunarodniy nauchnoissledovatel’skiy zhurnal = International Research Journal 2013;1:81–2. (In Russ.).

7. Mososyan M.S., Al-Shukri S.Kh., Esayan A.M. et al. Partial nephrectomy under regional ischemia provides good oncological outcomes and lowers the risk of chronic kidney disease and adverse cardio-vascular events in the patients with renal cell carcinoma. Vestnik Natsionalnogo mediko-khirurgicheskogo tsentra im. N.I. Pirogova = Bulletin of Pirogov National Medical and Surgical Center 2013;8(2):42–7. (In Russ.).

8. Shormanov I.S., Los M.S., Chirkov A.N. Prevention of total “warm ischemia” complications in kidney resection. Urologicheskie vedomosti = Urological Statements 2015;5:34–5. (In Russ.).

9. Smirnov A.V., Dobronravov V.A., Bodur-Oorzhak A.Sh. et al. Epidemiology and risk factors of chronic kidney diseases: regional level of the general problem. Terapevticheskiy arkhiv = Therapeutic Archive 2005;6:20–7. (In Russ.).

10. Smirnov A.V., Dobronravov V.A., Kayukov I.G. Cardiorenal continuum. Pathogenetical grounds of preventive nephrology. Nefrologiya = Nephrology 2005;9(3):7–15. (In Russ.).

11. Go A.S. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296–305. DOI: 10.1056/NEJMoa041031.

12. Campbell S.C. Guideline for management of the clinical T1 renal mass. J Urol 2009;182(4):1271–9. DOI: 10.1016/j.juro.2009.07.004.

13. State of oncological care in Russia in 2017. Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTS radiologii” Minzdrava Rossii, 2018. 236 p. (In Russ.).

14. Krambek A.E., Gettman M.T., Rohlinger A.L. et al. Diabetes mellitus and hypertension associatеd with schock wave lithotripsy of renal and proximal ureteral stones at 19 years of following. J Urol 2006;175(5):1742–7. DOI: 10.1016/S0022-5347(05)00989-4.

15. Eassa W.A., Sheir K.Z., Gad H.M. et al. Prospective study of the long-term effects of schock wave lithotripsy of renal functions and blood pressure. J Urol 2008;179(3): 964–8. DOI: 10.1016/j.juro.2007.10.055.

16. Cracco C.M. ECIRS (Endoscopic Combined Intrarenal Surgery) in the Galdakaomodifed supine valdiva position: a new life for percutaneus surgery? World J Urol 2011;29:821.

17. Isak W. Endoscopic-gualed renal access for percutaneus nephrolithiatomy: a comparative analysis. Urology 2013;81:251–6.

18. Jessen J.P., Honeck P., Knoll T., WendtNordahl G. Percutaneus nephrolithiatomy under combined sonographic/radiologic guided puncture: results of a learning curve using the modified Clavien grading system. World J Urol 2013;31(6):1599–603. DOI: 10.1007/s00345-012-1016-9.

19. Fankhauser C.D., Kranzbühler B., Poyet C. et al. Long-term adverse effects of extracorporeal shoch wave lithotripsy for nephrolithiasis and ureterolithiasis: a systematic review. Urology 2015;85(5):991–1006. DOI: 10.1016/j.urology.2014.12.014.

20. Falahatkar S., Allahkhah A., Kazemzadeh M. et al. Complete supine PCNL: ultrasound vs. fluoroscopic guided: a randomized clinical trial. Int Braz J Urol 2016;42(4):710–6. DOI: 10.1590/S16775538.IBJU.2014.0291.

21. Yuan D., Liu Y., Rao H. et al. Supine versus prone position in percutaneus nephrolithtomy for kidney calculi: a metaanalyses. J Endourol 2016;30(7):754–63. DOI: 10.1089/end.2015.0402.

22. Ljungberg B., Albiges L., Bensalah K. et al. Guadelamus on Renal Cell Carcinoma. Eur Ass Urol 2017:24–5.

23. Alekseeva G.N., Kiku P.F., Yudin S.V. et al. Comparative assessment of the quality of life of patients with kidney cancer after surgical treatment. Bulleten fiziologii i patologii dykhaniya = Bulletin of Physiology and Pathology of Breathing 2017;66:77–82. (In Russ.).

24. Nedoshivin A.O., Kutuzova A.E., Petrova N.N. Study of quality of life and psychological status of patients with chronic heart failure. Serdechnaya nedostatochnost’ = Heart Failure 2000;4(1):23–6. (In Russ.).

25. Dauletbakova D.N. Study of quality of life of patients with arterial hypertension using the SF-36 questionnaire. Molodoy ucheniy = Young Scientist 2018;23(209):23–8. (In Russ.).

26. Pikalova N.N. Study of quality of life of patients with COPD and CHF using the SF-36 questionnaire. Vestnik Novosibirskogo pedagogicheskogo universiteta = Novosibirsk State Pedagogical University Bulletin 2012;3(7):85–94. (In Russ.).

27. Shapovalov R.G., Silina L.V., Bobyntsev I.I. Studying quality of life indices in patients with diffused psoriasis by using questionnaire SF-36. Vestnik novykh meditsinskikh tekhnologiy = Journal of New Medical Technologies 2011;ХVIII(1):90–3. (In Russ.).

28. Metko E.E., Polyanskaya A.V. Surveyor SF-36 as a method of evaluating quality of life. Electronic scientific journal “Apriori. Seriya: Estestvennie i tekhnicheskie nauki” = “Apriori. Series: Natural and Technical Sciences” 2018;5. Available at: http://www.apriori-journal.ru/seria2/5-2018/MetikoPolyanskaya.pdf. (In Russ.).

29. Amirdzhanova V.M., Goryachev D.V., Korshunov N.I. et al. SF-36 questionnaire population quality of life indices (multi-center results quality of life research "Mirage"). Nauchnoprakticheskaya revmatologiya = Rheumatology Science and Practice 2008;1:36–48. (In Russ.).

30. Popov S.V., Skryabin O.N., Suleymanov M.M., Guseynov R.G. Comparative analysis of the EVS nephron-sparing operations for kidney tumors performed under warm ischemia and with preserved blood flow. Vrach-aspirant = Postgraduate Doctor 2015;1(68):54–8. (In Russ.).